The first report of a Mendelian disease arising from enhanced type I IFN production and signaling was of Aicardi–Goutieres syndrome (AGS) that described increased IFNα levels and activity in serum and cerebrospinal fluid (CSF) of the affected children [73]. The gene discussed is IFNA1; the disease is Aicardi-Goutières syndrome.